KGC
CLX icon

Kennon-Green & Company’s Clorox CLX Stock Holding History

Kennon-Green & Company’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Sell
10,662
-1,399
-12% -$134K 0.79% 30
2026
Q1 		$1.25M Buy
12,061
+407
+3% +$46.1K 1.02% 24
2025
Q4 		$1.18M Buy
11,654
+5,634
+94% +$612K 0.93% 26
2025
Q3 		$742K Buy
6,020
+3,251
+117% +$404K 0.58% 32
2025
Q2 		$342K Buy
2,769
+76
+3% +$10.1K 0.27% 36
2025
Q1 		$397K Buy
2,693
+275
+11% +$42K 0.32% 37
2024
Q4 		$393K Buy
2,418
+60
+3% +$9.81K 0.34% 38
2024
Q3 		$384K Buy
2,358
+312
+15% +$46.2K 0.32% 38
2024
Q2 		$279K Buy
2,046
+155
+8% +$21.5K 0.26% 39
2024
Q1 		$290K Buy
1,891
+71
+4% +$10.6K 0.27% 39
2023
Q4 		$260K Sell
1,820
-786
-30% -$105K 0.26% 39
2023
Q3 		$342K Buy
2,606
+57
+2% +$8.66K 0.34% 39
2023
Q2 		$405K Buy
2,549
+991
+64% +$160K 0.38% 37
2023
Q1 		$247K Buy
1,558
+66
+4% +$9.9K 0.23% 42
2022
Q4 		$209K Buy
+1,492
New +$212K 0.21% 44

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Kennon-Green & Company's CLX Position: Q2 2026 in Review

Kennon-Green & Company reduced its Clorox (CLX) stake by 12% in Q2 2026, selling an estimated $134K and leaving 10,662 shares worth $1.02M. The position accounts for 0.79% of the portfolio, ranked #30.

Kennon-Green & Company first reported a position in CLX in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.25M in Q1 2026. 1,036 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Kennon-Green & Company held 10,662 shares of Clorox worth $1.02M as of Q2 2026.
  • Kennon-Green & Company sold 1,399 Clorox shares in Q2 2026, an estimated $134K.
  • Clorox made up 0.79% of Kennon-Green & Company's portfolio in Q2 2026, its #30 holding.
  • Kennon-Green & Company first reported a position in Clorox in Q4 2022 and has held it in 15 quarters since.
  • Kennon-Green & Company's Clorox position peaked at $1.25M in Q1 2026.
  • 1,036 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Kennon-Green & Company's 13F filing for Q2 2026, filed 6 Aug 2026.